Related Experiment Video

Updated: Jul 25, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

Proposed definitive methods for measurement of plasma testosterone and 17 alpha-hydroxyprogesterone

S A Wudy, W M Teller

    Clinical Biochemistry
    |July 1, 1997
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure
    08:40

    Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure

    Published on: March 21, 2017

    An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
    06:18

    An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

    Published on: August 13, 2019

    Related Experiment Videos

    Last Updated: Jul 25, 2026

    Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
    08:02

    Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

    Published on: April 25, 2016

    Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure
    08:40

    Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure

    Published on: March 21, 2017

    An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
    06:18

    An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

    Published on: August 13, 2019

    Related Concept Videos

    Drug Concentrations: Measurements01:23

    Drug Concentrations: Measurements

    Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
    Plasma —...
    Measurement of Bioavailability: Pharmacodynamic Methods01:20

    Measurement of Bioavailability: Pharmacodynamic Methods

    Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.

    Articles linked to this work by shared authors, journal, and citation graph.

    Targeted quantitative analysis of urinary bile acids by liquid chromatography-tandem mass spectrometry: Method development and application to healthy and obese children.

    The Journal of steroid biochemistry and molecular biology·2025

    Targeted LC-MS/MS analysis of steroid glucuronides in human urine.

    The Journal of steroid biochemistry and molecular biology·2020

    Peptide hormone analysis in diagnosis and treatment of Differences of Sex Development: joint position paper of EU COST Action 'DSDnet' and European Reference Network on Rare Endocrine Conditions.

    European journal of endocrinology·2020

    Characterizing the steroidal milieu in amniotic fluid of mid-gestation: A GC-MS study.

    The Journal of steroid biochemistry and molecular biology·2019

    Prenatal maternal stress is associated with lower cortisol and cortisone levels in the first morning urine of 45-month-old children.

    Psychoneuroendocrinology·2019

    GENETICS IN ENDOCRINOLOGY: Approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 ‘DSDnet’

    European journal of endocrinology·2018

    Primer part 3 - evaluating, disseminating and sustaining a laboratory quality improvement project.

    Clinical biochemistry·2026

    Detection of individual false-low total bilirubin results in neonates and young infants using the bilirubin-to-icteric index ratio.

    Clinical biochemistry·2026

    From selective testing to actionable prevention: The VALOR-ED pathway.

    Clinical biochemistry·2026

    Intraoperative PTH monitoring during parathyroid surgery: when 10 minutes is not enough-Can delayed decline be predicted?

    Clinical biochemistry·2026

    Non-steroidal anti-inflammatory drugs and CYP2C9 - Impacts of genetics and phenoconversion on the risk of adverse effects.

    Clinical biochemistry·2026

    Unexpected increase in false-positive results following benzodiazepine immunoassay reformulation.

    Clinical biochemistry·2026

    A rare intravenous paraquat exposure presenting with novel and atypical severe clinical manifestations.

    Indian journal of pharmacology·2026

    Risk of septic arthritis following corticosteroid and platelet-rich plasma injections: A multicenter retrospective review.

    PM & R : the journal of injury, function, and rehabilitation·2026

    Beyond traditional sleeping pills: safety, efficacy and multidisease potential of three approved orexin receptor antagonists.

    Frontiers in psychiatry·2026

    Informing the patient of the placebo option: an ethical necessity likely to reduce inappropriate psychotropic prescriptions?

    Therapeutic advances in psychopharmacology·2026

    Ruxolitinib for rheumatic disease-associated macrophage activation syndrome in children: a retrospective cohort study.

    Frontiers in immunology·2026

    Adverse drug events in hospitalized COVID-19 patients: a pharmacovigilance perspective on ICU management and fentanyl exposure.

    Frontiers in epidemiology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us